Loading provider…
Loading provider…
Dermatology Physician in Glen Rock, NJ
NPI: 1396704755Primary Practice Location
Dermatology Associates of Glen Rock, P.A.
348 Maple S Ave, Glen Rock, NJ
Primary Employer
Dermatology Associates of Glen Rock, P.A.
dermatologyassociatesgr.com
HQ Phone
Get M.D. Jonathan's Phone Numberphone_androidMobile
Get M.D. Jonathan's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNJ State Medical License
NJ State Medical License
2000 - 2027
NY State Medical License
1997 - 2027

American Board of Dermatology
Dermatology
NYU Grossman School of Medicine
med.nyu.edu
Residency • Dermatology
1997 - 2000
New York Presbyterian Hospital (Columbia Campus)
Internship • Internal Medicine
1996 - 1997
New York University School of Medicine
Medical School
Until 1996
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 758 | 1,088 |
| 2 | 11102Tangential biopsy of single skin lesion | 545 | 708 |
| 3 | 17000Destruction of skin growth | 449 | 778 |
| 4 | 99212Established patient outpatient visit, total time 10-19 minutes | 308 | 440 |
| 5 | 17003Destruction of 2-14 skin growths | 237 | 779 |
Authors: Gropper, Savion, Cepero, Ana Luisa, Dosik, Jonathan S, LaStella, Phillip, Siemetzki, Heinrich, Wigger-Alberti, Walter
Journal: Future Microbiol
Authors: Dosik, Jonathan S, Arsonnaud, Stephanie
Journal: J Drugs Dermatol
Authors: Marshall-Hudson, Allyson, Tuley, Michael, Damstra, Maureen, Dosik, Jonathan S, Myntti, Matthew F, Porral, Dianne, Palomo, Janel
Journal: J Clin Aesthet Dermatol
Lead Sponsor: MC2 Therapeutics
Intervention / Treatment: DRUG: Challenge: Control, irradiation, DRUG: Induction: Application of MC2-01 Cream, irradiation, DRUG: Induction: Application of MC2-01 Cream, no irradiation, DRUG: Induction: Applications of MC2-01 vehicle, irradiation, DRUG: Induction: Applications of MC2-01 vehicle, no irradiation, DRUG: Challenge: Application of MC2-01 Cream, irradiation, DRUG: Challenge: Application of MC2-01 Cream, no irradiation, DRUG: Challenge: Applications of MC2-01 vehicle, irradiation, DRUG: Challenge: Applications of MC2-01 vehicle, no irradiation
Lead Sponsor: SRI International
Collaborators: TKL Research, Inc.
Intervention / Treatment: DRUG: TDS Lidocaine 5%; RLD, DRUG: TDS Lidocaine 5%; generic
Lead Sponsor: Dr. Reddy's Laboratories Limited
Intervention / Treatment: DRUG: Placebo, DRUG: Abametapir Lotion 0.74% w/w, DRUG: Sodium Lauryl Sulfate, DRUG: Saline 0.9%